As of 2026-03-08, the Relative Valuation of ImmunoGen Inc (IMGN) is (6.01) USD. This relative valuation is based on P/E multiples. With the latest stock price at 31.23 USD, the upside of ImmunoGen Inc based on Relative Valuation is -119.3%.
The range of the Relative Valuation is (5.36) - (6.37) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 20.4x - 26.5x | 23.4x |
| Forward P/E multiples | 20.3x - 24.2x | 22.3x |
| Fair Price | (5.36) - (6.37) | (6.01) |
| Upside | -117.2% - -120.4% | -119.3% |
| Date | P/E |